Evaluation of association between precolectomy thrombocytosis and the occurrence of inflammatory pouch disorders

Diseases of the Colon and Rectum

Volumn 52, Issue 11, 2009, Pages 1912-1918

  Lian, Lei ^a   Fazio, Victor W ^a   Lavery, Ian C ^a   Hammel, Jeff ^a   Remzi, Feza H ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Crohn's disease of the pouch; ileal pouch anal anastomosis; platelet count; pouchitis; restorative proctocolectomy; ulcerative colitis

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ACUTE POUCHITIS; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC POUCHITIS; CLINICAL EVALUATION; COLON POUCH; CROHN DISEASE; CUFFITIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPY; ENTERITIS; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM POUCH; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROCTOCOLECTOMY; SMOKING; THROMBOCYTE COUNT; THROMBOCYTOSIS; ULCERATIVE COLITIS; ANASTOMOSIS; CHI SQUARE DISTRIBUTION; NONPARAMETRIC TEST; PREDICTION AND FORECASTING; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; ANASTOMOSIS, SURGICAL; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; COLONIC POUCHES; CROHN DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 75349107920     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181b300f4     Document Type: Article

References (49)

1. Shen B, Remzi FH, Lavery IC, Lashner BA, Fazio VW. A proposed classification of ilealpouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008;6:145-58.
2. Shen B, Fazio VW, Remzi FH, et al. Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch. Dis Colon Rectum 2007;50:1450-9.
3. Shen B, Remzi FH, Brzezinski A, et al. Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch. Inflamm Bowel Dis 2008;14:942-8.
4. Shen B. Crohn's disease ofthe ilealpouch: Reality, diagnosis, and management. Inflamm Bowel Dis 2009;15:284-94.
5. Fazio VW, Tekkis PP, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg 2003;238:605-14.
6. Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003;238:229-34.
7. Shen B, Fazio VW, Remzi FH, Lashner BA. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol 2005;100:2796-807.
8. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomosis: Complications and function in 1005 patients. Ann Surg 1995; 222:120-7.
9. Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV. Pre- operative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998;227:654-62.
10. Mor IJ, Vogel JD, da Luz Moreira A, Shen B, Hammel J, Remzi FH. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008;51:1202-7.
11. Achkar JP, Al-Haddad M, Lashner B, et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005;3:60-6.
12. Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 2008;14:20-8.
13. Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: Multivariate analysis. Scand J Gastroenterol 2003;38:1055-8.
14. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcer- ative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001;49:671-7.
15. Shen B, Remzi FH, Nutter B, et al. Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis. Am J Gastroenterol 2009;104:655-64.
16. Merrett MN, Mortensen N, Kettlewell M, Jewell DO. Smoking may prevent pouchitis in patients with restorative proctocolec- tomy for ulcerative colitis. Gut 1996;38:362-4.
17. Shen B, Remzi FH, Hammel JP, et al. Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch. Inflamm Bowel Dis 2009;15:163-70.
18. Melmed GY, Fleshner PR, Bardakcioglu O, et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008;51:100-8.
19. Fleshner P, Ippoliti A, Dubinsky M, et al. A prospective multi- variate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2007; 5:952-8.
20. Okon A, Dubinsky M, Vasiliauskas EA, et al. Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis. Am Surg 2005;71:821-6.
21. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: A Pouchitis Disease Activity Index. Mayo Clin Proc 1994;69:409-15.
22. Shen B, Achkar JP, Connor JT, et al. Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchi- tis. Dis Colon Rectum 2003;46:748-53.
23. Shen B, Fazio VW, Remzi FH, et al. Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol 2006;101:2760-8.
24. Shen B, Lashner BA. Pouchitis: A spectrum of diseases. Curr Gastroenterol Rep 2005;7:404-11.
25. Shen B, Fazio VW, Remzi FH, et al. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:81-9. (Pubitemid 43129528)
26. Buckell NA, Lennard-Jones JE, Hernandez MA, Kohn J, Riches PG, Wadsworth J. Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut 1979;20:22-7.
27. Heimann TM, Greenstein AJ, Mechanic L, Aufses AH Jr. Early complications following surgical treatment for Crohn's disease. Ann Surg 1985;201:494-8.
28. Hoda KM, Collins JF, Knigge KL, Deveney KE. Predictors of pouchitis after ileal pouch-anal anastomosis: A retrospective review. Dis Colon Rectum 2008;51:554-60.
29. Dooley DP, Mills GM, Spiva DA. Immune thrombocytopenia and ulcerative colitis. South Med J 1986;79:1044-5.
30. Kosmo MA, Bordin G, Tani P, McMillan R. Immune thrombo- cytopenia and Crohn's disease. Ann Intern Med 1986;104:136.
31. Talstad I, Rootwelt K, Gjone E. Thrombocytosis in ulcerative colitis andCrohn's disease. Scand J Gastroenterol 1973;8:135-8.
32. Knot E, Ten Cate JW, Leeksma OC, Tytgat GN, Vreeken J. No evidence for a prethrombotic state in stable chronic inflammatory bowel disease. J Clin Pathol 1983;36:1387-90.
33. Harries AD, Fitzsimons E, Fifield R, Dew MJ, Rhoades J. Platelet count: A simple measure of activity in Crohn's disease. BMJ 1983;286:1476.
34. Linskens RK, van Bodegraven AA, Schoorl M, Tuynman HA, Bartels P. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci 2001;46:644-8.
35. M J Webberley, M T Hart, V Melikian. Thromboembolism in inflammatory bowel disease: Role of platelets. Gut 1993;34: 247-51.
36. Brihier H, Nion-Larmurier I, Afchain P, et al. Intestinal perforation in Crohn's disease: factors predictive of surgical resection. Gastroenterol Clin Biol 2005;29:1105-11.
37. Van Wersch JW, Houben PP, Rijken J. Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. K Clin Chem Clin Biochem 1990;28:513-7.
38. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994;106:840-5.
39. Henn V, Slupsky JR, Gräfe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4.
40. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: Useful, magic, or unnecessary toys? Gut 2006;55:426-31.
41. Duffy M, O'Mahony L, Coffey JC, et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002;45: 384-8.
42. Nasmyth DG, Godwin PGR, Dixon MF, Williams NS, Johnston D. Ileal ecology after pouch anal anastomosis or ileostomy. Gastroenterology 1989;96:817-24.
43. Komanduri S, Gillevet PM, SikaroodiM, Mutlu E, Keshavarzian A. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007; 5:352-60.
44. Sokol H, Lay C, Seksik P, Tannock GW. Analysis of bacterial bowel communities of IBD patients: what has it revealed? In-flamm Bowel Dis 2008;14:858 -67.
45. Ohge H, Furne JK, Springfield J, Rothenberger DA, Madoff RD, Levitt MD. Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005;48:469-75. (Pubitemid 40767867)
46. Shen B, Jiang ZD, Fazio VW, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008;6:782-8.
47. Munoz-Juarez M, Pemberton JH, Sandborn WJ, Tremaine WJ, Dozois RR. Misdiagnosis of specific cytomegalovirus infection of ileoanal pouch as a refractory idiopathic chronic pouchitis: Report oftwo cases. Dis Colon Rectum 1999;42:117-20.
48. Mooka D, Furth EE, MacDermott RP, Lichtenstein GR. Pouchi- tis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998;93:264-6.
49. Küahbacher T, Ott SJ, Helwig U, et al. Bacterial and fungal mi- crobiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006;55:833-41.